Researchers explored the impact of tapering TNF inhibitor therapy until discontinuation vs maintaining stable treatment on the risk for disease activity flares among patients with RA in clinical remission for at least one year.
Investigators compared the effects of oral and intravenous steroids used to treat several renal complications throughout the disease course of Henoch-Schönlein purpura.
Findings seen in the year following policy changes
When stratifying for thumb and finger osteoarthritis, no intervention was superior to placebo
In a randomized trial, researchers assessed the clinical and cost-effectiveness of nurse-delivered sleep restriction therapy in a primary care setting for the treatment of insomnia.
Patient and graft survival rates were 85.5% and 75.8%, respectively, at 5 years.
A study was conducted to determine the relationship between social determinants of health and HRQOL in patients with heart disease.
Researchers conducted a meta-analysis to assess the relationship between symptoms and treatment outcomes of patients with polycystic ovary syndrome.
Researchers compared pain scores among 3 targeted treatment strategies and identified characteristics predictive of the persistence of pain among children with nonsystemic juvenile idiopathic arthritis.
Investigators assessed rates of drug retention and reasons for discontinuation among patients with rheumatoid arthritis treated with bDMARDs and JAK inhibitors.
Strong association seen for deviations from normal ‘clock’ of activity and sleep during pregnancy with pregnancy outcomes
Increases in glycemic index and glycemic load positively associated with weight gain in men and women
After the COVID-19 pandemic began, the rate of opioid overdose deaths immediately increased in non-Hispanic Black patients by 63.6%.
Hypophosphatasia (HPP) and FM have similar, nonspecific clinical characteristics. As treatments for the 2 conditions may differ, accurate diagnosis optimizes outcomes.
Researchers evaluated fracture prevention care patterns among older patients in the UK and Canada with high cumulative exposure to oral corticosteroids.
A study was conducted to determine the cardiovascular effects of concomitant MRAs and SGLT2 inhibitors in patients with heart failure.
Researchers developed a guide for clinicians to use ozanimod for the treatment of moderate to severe ulcerative colitis.
Researchers assessed the safety and efficacy of tart cherry supplementary citrate use among patients with gout initiating urate lowering therapy.
Investigators assessed the safety and efficacy of nonpharmacological interventions for reducing fatigue among patients with inflammatory rheumatic and musculoskeletal diseases.
Findings seen for academic medical leadership, with surgical specialties generally having lower leadership diversity than average
Race disparities reported in 10 of 20 studies; all showed that Black women had lower use, prescribing, counseling for MHT
Researchers conducted a trial tht included 32 patients to compare outcomes of C-LRFA and FJI for joint pain relief.
The safety and efficacy of naloxegol doses were compared in patients with opioid-induced constipation.
Researchers assessed the efficacy of dupilumab in improving nocturnal symptoms and asthma control in patients with T2 asthma and high sleep disturbance.
In a study, diabetes increased the odds of pathologic upgrading of renal cell carcinoma by 65% and 32%, among patients undergoing partial and radical nephrectomy, respectively.
Investigators assessed the efficacy of tofacitinib for the treatment of enthesitis among patients with psoriatic arthritis and its impact on disease activity and patient reported outcomes.
Researchers compared patient reported outcomes measures of individuals with calcium pyrophosphate deposition disease vs those with gout and osteoarthritis.
Child mental health declined overall during pandemic, but decline was greatest in children with employed parents or from higher-income households
However, total physical activity found to be more important than consistency or timing
A Prescription Drug User Fee Act target date of January 26th, 2024 has been assigned to the application.
